State Ledger
Company profile

MapLight Therapeutics, Inc. CIK 1770069

Ticker
MPLT (Nasdaq)
Industry
Pharmaceutical Preparations
Headquarters
Redwood City, CA 94063
Fiscal year end
2025 (FY)
Market Data
Close
$7.85
Change
-$0.76
Change %
-8.83%
Volume
11,235

MPLT · trading date Oct 13, 2026 · previous close $8.61 · source: Alpaca (IEX feed, not consolidated full-market data).

Key Financials
Revenue
—
Net income
-$161.15M
Total assets
$479.51M
Total liabilities
$21.14M
Stockholders' equity
$458.37M
Cash & equivalents
$46.73M
Operating income
-$169.08M
Operating cash flow
-$138.14M
Capital expenditures
$473.0K

Fiscal year 2025, via 10-K filed 2026-03-26. A dash means this figure wasn't reported in the source filing under a field State Ledger recognizes - not that the value is zero.

Financial Performance
Operating margin
—
Net margin
—
Free cash flow
-$138.61M
Free cash flow margin
—
Liabilities / assets
4.4%
Equity / assets
95.6%
CapEx / revenue
—
Operating cash flow / net income
0.86×

Derived from the fiscal year 2025 figures above. These metrics are mathematical calculations and do not represent a rating or assessment of the company.

Financial History
Fiscal yearRevenueNet incomeAssetsLiabilitiesEquity
2025 — -$161.15M $479.51M $21.14M $458.37M
2024 — -$77.58M $136.92M $21.72M -$193.63M
Company Details
SIC code
2834
State of incorporation
DE
Active filer
Yes
Most recent SEC filing
Form S-1/A
2026-09-18
Financials filed via
Form 10-K
filed 2026-03-26

"Most recent SEC filing" may differ from the filing used for the financial figures above.

Location
Redwood City, CA 94063
800 CHESAPEAKE DRIVE
Data & Methodology

SEC EDGAR submissions API (identity, collected Sep 19, 2026, 15:11 UTC) and SEC XBRL Company Facts API (financials, collected Sep 26, 2026, 15:18 UTC) · figures as originally filed, not restated · a dash always means a value wasn't reported, never a real zero.

← Back to California — Public Companies